tapinarof
General
Pronunciation:
ta-pin-ar-of
Trade Name(s)
- Vtama
Ther. Class.
antipsoriatics
Pharm. Class.
aryl hydrocarbon receptor agonists
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Tapinarof." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580094/7/tapinarof.
Vallerand AHA, Sanoski CAC, . Tapinarof. Davis's Drug Guide. F.A. Davis Company; 2025. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580094/7/tapinarof. Accessed April 21, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Tapinarof. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580094/7/tapinarof
Vallerand AHA, Sanoski CAC, . Tapinarof [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 April 21]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580094/7/tapinarof.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - tapinarof
ID - 3580094
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580094/7/tapinarof
PB - F.A. Davis Company
ET - 19
DB - Nursing Central
DP - Unbound Medicine
ER -